Dr. Raed Benkhadra, MD

Dr. Benkhadra practices at Samaritan Pacific Communities Hospital in Newport, Oregon, part of MultiCare Health System.

Dr. Benkhadra's NPI, 1255837746, was assigned on April 3, 2018. Dr. Benkhadra holds Oregon license MD217551.

Dr. Benkhadra's primary practice is Samaritan Pacific Communities Hospital, at 930 SW Abbey Street, Newport, OR 97365 in Lincoln County. The practice phone is (541) 265-2244.

Dr. Benkhadra's primary practice is Samaritan Pacific Communities Hospital in Newport, Oregon, part of MultiCare Health System. Dr. Benkhadra is also affiliated with Samaritan Albany General Hospital. The medical group on file is Samaritan Lebanon Community Hospital. Dmand AI also links Dr. Benkhadra to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Benkhadra practices, 8 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Benkhadra's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Benkhadra is licensed in Oregon.

CMS data shows 53 Medicare services from Dr. Benkhadra across 2 procedure codes in 2024, for 28 Medicare patients. Medicare paid $2,162 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 28 Medicare patients who saw Dr. Benkhadra in 2024. The largest group is 65 to 74, with 14 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Benkhadra's median patient age at 70, with 61% women.

In 2024, Dr. Benkhadra wrote 120 Medicare Part D claims for 37 patients. 84% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $317 in total drug cost. In 2021, CMS named 157 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Benkhadra for performance year 2024, reported as part of a group. Dr. Benkhadra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Benkhadra as offering telehealth.

Dmand AI links 15 papers to Dr. Benkhadra, published from 2017 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Consumer Health Information and Internet. Dr. Benkhadra has published most often in Bladder Cancer. Dr. Benkhadra's most frequent co-authors are Mohammad Hassan Murad, MD, Omar Alhalabi, MD and Wigdan Hassan Eltayeb Farah, MBBS.

CMS Open Payments shows 29 general payments to Dr. Benkhadra from 18 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 85% of the total. Incyte Corporation paid the most, $329.